UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Journal of thoracic oncology, 2013-07, Vol.8 (7), p.823-859

2013

Volltextzugriff (PDF)

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Archives of pathology & laboratory medicine (1976), 2013-06, Vol.137 (6), p.828-860

2013

Volltextzugriff (PDF)

Lung cancer biomarkers: present status and future developments

Archives of pathology & laboratory medicine (1976), 2013-09, Vol.137 (9), p.1191-1198

2013

Volltextzugriff (PDF)

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group

Archives of pathology & laboratory medicine, 2013-05, Vol.137 (5), p.647-667

2013

Volltextzugriff (PDF)

Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society

Archives of pathology & laboratory medicine (1976), 2018-02, Vol.142 (2), p.253-262

2018

Volltextzugriff (PDF)

Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray

Archives of pathology & laboratory medicine (1976), 2012-02, Vol.136 (2), p.163-171

2012

Volltextzugriff (PDF)

Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society

Archives of pathology & laboratory medicine (1976), 2016-04, Vol.140 (4), p.341-344

2016

Volltextzugriff (PDF)

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society

Archives of pathology & laboratory medicine (1976), 2016-11, Vol.140 (11), p.1267-1272

2016

Volltextzugriff (PDF)

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society

Archives of pathology & laboratory medicine (1976), 2018-03, Vol.142 (3), p.408-419

2018

Volltextzugriff (PDF)

Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas

Modern pathology, 2008-06, Vol.21 (6), p.742-747

2008

Volltextzugriff (PDF)

Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma

Clinical lung cancer, 2020-09, Vol.21 (5), p.437-442

2020

Volltextzugriff (PDF)

Lung cancer genotype-based therapy and predictive biomarkers: present and future

Archives of pathology & laboratory medicine (1976), 2012-12, Vol.136 (12), p.1482-1491

2012

Volltextzugriff (PDF)

Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents

Archives of pathology & laboratory medicine (1976), 2013-02, Vol.137 (2), p.241-244

2013

Volltextzugriff (PDF)

Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group

Archives of pathology & laboratory medicine (1976), 2009-08, Vol.133 (8), p.1317-1331

2009

Volltextzugriff (PDF)

Utility of immunohistochemistry in the diagnosis of pleuropulmonary and mediastinal cancers: a review and update

Archives of pathology & laboratory medicine (1976), 2014-12, Vol.138 (12), p.1611-1628

2014

Volltextzugriff (PDF)

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society

Archives of pathology & laboratory medicine (1976), 2017-03, Vol.141 (3), p.437-444

2017

Volltextzugriff (PDF)

Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung

Archives of pathology & laboratory medicine (1976), 2013-09, Vol.137 (9), p.1274-1281

2013

Volltextzugriff (PDF)

Revolution in lung cancer: new challenges for the surgical pathologist

Archives of pathology & laboratory medicine (1976), 2011-01, Vol.135 (1), p.110-116

2011

Volltextzugriff (PDF)

Impact of Recent Developments in Lung Cancer on the Practice of Pathology

Archives of pathology & laboratory medicine (1976), 2016-04, Vol.140 (4), p.322-325

2016

Volltextzugriff (PDF)

Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis

Proceedings of the National Academy of Sciences - PNAS, 2010-01, Vol.107 (2), p.888-893

2010

Volltextzugriff (PDF)

Pathology of the pleura: What the pulmonologists need to know

Respirology (Carlton, Vic.), 2011-04, Vol.16 (3), p.430-438

2011

Volltextzugriff (PDF)

Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology Society

Archives of pathology & laboratory medicine (1976), 2016-11, Vol.140 (11), p.1281-1284

2016

Volltextzugriff (PDF)

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Archives of pathology & laboratory medicine (1976), 2018-03, Vol.142 (3), p.321-346

2018

Volltextzugriff (PDF)

Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies

Archives of pathology & laboratory medicine (1976), 2005-11, Vol.129 (11), p.1421-1427

2005

Volltextzugriff (PDF)

1 – 25 von 492

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(277)
Mit Volltextzugriff
(458)

Publikationsform

Sprache

Englisch
(491)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Lung cancer biomarkers: present status and future developments

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group

Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society

Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray

Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society

Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas

Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma

Lung cancer genotype-based therapy and predictive biomarkers: present and future

Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents

Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group

Utility of immunohistochemistry in the diagnosis of pleuropulmonary and mediastinal cancers: a review and update

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society

Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung

InSituPathologists: how the #USCAP2015 meeting went viral on Twitter and founded the social media movement for the United States and Canadian Academy of Pathology

Revolution in lung cancer: new challenges for the surgical pathologist

Impact of Recent Developments in Lung Cancer on the Practice of Pathology

Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis

Pathology of the pleura: What the pulmonologists need to know

Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology Society

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies

Suchergebnisse filtern